Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Details Narrative)

v3.21.2
Stockholders’ Equity (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 30, 2021
Mar. 15, 2021
Sep. 30, 2021
Mar. 31, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Dec. 31, 2020
Feb. 23, 2021
Class of Stock [Line Items]                  
Stock Issued During Period, Shares, Conversion of Convertible Securities                
Stock Issued During Period, Value, Conversion of Convertible Securities            
Fair Value Adjustment of Warrants       $ (214,000)    
Preferred Stock Warrants [Member]                  
Class of Stock [Line Items]                  
Stock Issued During Period, Shares, Conversion of Convertible Securities           43,107      
Merger Agreement [Member]                  
Class of Stock [Line Items]                  
Warrants and rights issue     2,157,686     $ 2,157,686      
Merger Agreement [Member] | Investor [Member]                  
Class of Stock [Line Items]                  
Class of Warrant or Right, Number of Securities Called by Warrants or Rights                 143,890
Class of Warrant or Right, Exercise Price of Warrants or Rights                 $ 5.9059
Fair Value Adjustment of Warrants       $ 214,000          
Warrants fair value disclosure     $ 421,000     $ 421,000      
Series A Convertible Preferred Stock [Member]                  
Class of Stock [Line Items]                  
[custom:TemporaryEquityShareOutstanding-0]               4,611,587  
Stock Issued During Period, Shares, Conversion of Convertible Securities               5,973,509  
Series B Convertible Preferred Stock [Member]                  
Class of Stock [Line Items]                  
[custom:TemporaryEquityShareOutstanding-0]               3,489,470  
Stock Issued During Period, Shares, Conversion of Convertible Securities               4,524,171  
Series B Preferred Stock [Member]                  
Class of Stock [Line Items]                  
Sale of Stock, Number of Shares Issued in Transaction       235,877          
Sale of Stock, Consideration Received on Transaction       $ 1,250,000          
Series C Convertible Preferred Stock [Member] | Cancer Genetics Inc [Member] | Merger Agreement [Member]                  
Class of Stock [Line Items]                  
Stock Issued During Period, Shares, Conversion of Convertible Securities 699,395                
Stock Issued During Period, Value, Conversion of Convertible Securities   $ 2,000,000.0